Streamline Health Company Leadership

STRM Stock  USD 4.60  0.30  6.98%   
Streamline Health employs about 77 people. The company is managed by 14 executives with a total tenure of roughly 7 years, averaging almost 0.0 years of service per executive, having 5.5 employees per reported executive. Analysis of Streamline Health's management performance can provide insight into the firm performance.
Thomas Gibson  President
CFO, Senior Vice President
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Streamline Health Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Streamline Health's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Streamline Health's future performance. Based on our forecasts, it is anticipated that Streamline will maintain a workforce of about 100 employees by March 2025.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid

Streamline Health Management Team Effectiveness

The company has return on total asset (ROA) of (0.1054) % which means that it has lost $0.1054 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8009) %, meaning that it created substantial loss on money invested by shareholders. Streamline Health's management efficiency ratios could be used to measure how well Streamline Health manages its routine affairs as well as how well it operates its assets and liabilities. As of the 1st of February 2025, Return On Tangible Assets is likely to grow to -1.93. In addition to that, Return On Capital Employed is likely to grow to -0.77. At this time, Streamline Health's Total Current Assets are very stable compared to the past year. As of the 1st of February 2025, Fixed Asset Turnover is likely to grow to 242.65, while Non Current Assets Total are likely to drop about 19.3 M.
As of the 1st of February 2025, Common Stock Shares Outstanding is likely to drop to about 4.1 M. In addition to that, Net Loss is likely to grow to about (9.7 M)

Streamline Health Workforce Comparison

Streamline Health Solutions is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 14,665. Streamline Health maintains roughly 77.0 in number of employees contributing less than 1% to equities under Health Care industry.

Streamline Health Profit Margins

The company has Profit Margin (PM) of (0.93) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.71) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.71.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.40.46
Fairly Down
Very volatile

Streamline Health Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Streamline Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Streamline Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Streamline Health insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2024-06-01
1.5
3
2
 470,000 
 40,666 
2024-03-01
2.0
4
2
 1,627,632 
 921,053 
2023-12-01
0.1429
1
7
 50,000 
 207,066 
2023-06-01
1.75
7
4
 968,621 
 40,428 
2022-12-01
3.0
9
3
 1,980,300 
 0.00 
2021-12-01
0.25
1
4
 100,000 
 33,863 
2021-06-01
0.4286
3
7
 112,500 
 56,444 
2021-03-01
1.375
11
8
 3,325,000 
 56,181 
2020-06-01
1.75
7
4
 648,245 
 22,067 
2020-03-01
0.125
1
8
 100,000 
 253,980 
2019-12-01
1.1667
7
6
 2,243,137 
 20,692 
2019-09-01
0.4286
3
7
 275,000 
 86,217 
2019-06-01
0.6
3
5
 162,518 
 86,159 
2019-03-01
16.0
16
1
 566,666 
 0.00 
2018-09-01
0.5
2
4
 12,000 
 365.00 
2018-06-01
0.1429
1
7
 31,250 
 77,941 
2017-06-01
11.0
11
1
 278,137 
 6,787 
2017-03-01
5.0
5
1
 251,387 
 21,269 
2016-06-01
7.0
7
1
 353,225 
 0.00 
2016-03-01
5.3333
16
3
 890,249 
 8,241 
2015-09-01
6.0
6
1
 332,500 
 5,800 
2015-03-01
11.5
23
2
 368,889 
 39,960 
2014-09-01
9.6667
29
3
 514,062 
 17,567 
2014-03-01
0.5
1
2
 50,000 
 200,000 
2013-12-01
1.0
2
2
 2,421 
 25,000 
2013-09-01
1.6667
5
3
 135,487 
 55,500 
2013-06-01
2.2857
16
7
 255,687 
 110,341 
2013-03-01
0.1163
5
43
 450,000 
 777,265 
2012-12-01
4.5
9
2
 722,835 
 34,000 
2012-06-01
0.2174
10
46
 240,199 
 262,873 
2012-03-01
5.0
5
1
 210,180 
 100,000 
2011-06-01
5.6667
17
3
 253,892 
 300,000 
2011-03-01
1.3333
4
3
 500,000 
 50,000 
2010-12-01
1.5
3
2
 74,488 
 43,481 
2010-06-01
0.7647
13
17
 227,102 
 108,064 
2010-03-01
0.2273
5
22
 38,238 
 110,877 
2009-12-01
1.0
3
3
 20,080 
 20,000 
2009-09-01
0.0909
1
11
 5,000 
 53,835 
2009-06-01
0.6
6
10
 50,005 
 54,715 
2009-03-01
6.0
6
1
 275,382 
 0.00 
2008-06-01
4.0
8
2
 74,323 
 5,000 
2007-12-01
0.3
3
10
 18,600 
 92,130 
2007-06-01
0.8125
13
16
 56,600 
 156,235 
2006-12-01
0.0164
1
61
 15,000 
 174,855 
2006-09-01
1.0
1
1
 600.00 
 1,250 
2006-06-01
0.6429
9
14
 38,247 
 51,321 
2005-12-01
0.2727
3
11
 16,000 
 130,000 
2005-06-01
0.5
2
4
 17,124 
 45,000 
2004-12-01
3.0
3
1
 20,000 
 0.00 

Streamline Health Notable Stakeholders

A Streamline Health stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Streamline Health often face trade-offs trying to please all of them. Streamline Health's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Streamline Health's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Wyche IIIExecutive ChairmanProfile
Thomas GibsonCFO, Senior Vice PresidentProfile
Ben StilwillPresidentProfile
Donald VickDirector AnalyticsProfile
Bryant ReevesInterim StaffProfile
Lance SeachSenior DevelopmentProfile
Jawad ShaikhChief OfficerProfile
Benjamin StilwillChief OfficerProfile
Jacob GoldbergerDirector FPAProfile
Wendy LucioChief OfficerProfile
Wendy LovvornChief OfficerProfile
Amy SeberoChief OfficerProfile
Bryant IIIChief OfficerProfile
MB CCSVP eValuatorProfile

About Streamline Health Management Performance

The success or failure of an entity such as Streamline Health often depends on how effective the management is. Streamline Health management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Streamline management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Streamline management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(2.03)(1.93)
Return On Capital Employed(0.81)(0.77)
Return On Assets(0.52)(0.49)
Return On Equity(0.89)(0.85)

Streamline Health Workforce Analysis

Traditionally, organizations such as Streamline Health use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Streamline Health within its industry.

Streamline Health Manpower Efficiency

Return on Streamline Health Manpower

Revenue Per Employee293.5K
Revenue Per Executive1.6M
Net Loss Per Employee242.8K
Net Loss Per Executive1.3M
When determining whether Streamline Health is a strong investment it is important to analyze Streamline Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Streamline Health's future performance. For an informed investment choice regarding Streamline Stock, refer to the following important reports:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Streamline Health Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Streamline Health. If investors know Streamline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Streamline Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
12.131
Earnings Share
(2.35)
Revenue Per Share
5.249
Quarterly Revenue Growth
(0.01)
Return On Assets
(0.11)
The market value of Streamline Health is measured differently than its book value, which is the value of Streamline that is recorded on the company's balance sheet. Investors also form their own opinion of Streamline Health's value that differs from its market value or its book value, called intrinsic value, which is Streamline Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Streamline Health's market value can be influenced by many factors that don't directly affect Streamline Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Streamline Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Streamline Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Streamline Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.